Covered recipient · General Payments record
LYNN MISKOVICH
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$2,377.82
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $408.77 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lexicon Pharmaceuticals, Inc. | $120.69 | 1 |
| Inari Medical, Inc. | $94.48 | 1 |
| Gilead Sciences, Inc. | $47.66 | 2 |
| Lilly USA, LLC | $44.44 | 2 |
| Amgen Inc. | $26.90 | 1 |
| Xeris Pharmaceuticals, Inc. | $23.33 | 1 |
| Novo Nordisk AS | $19.12 | 1 |
| Acerta Pharma LLC | $16.47 | 1 |
| EMD Serono, Inc. | $15.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $26.90 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117329898 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.47 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105545663 | CMS |
| EMD Serono, Inc. | $15.68 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120221549 | CMS |
| Gilead Sciences, Inc. | $18.62 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133663388 | CMS |
| Gilead Sciences, Inc. | $29.04 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133663390 | CMS |
| Inari Medical, Inc. | $94.48 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140188166 | CMS |
| Lexicon Pharmaceuticals, Inc. | $120.69 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081717952 | CMS |
| Lilly USA, LLC | $23.66 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135800568 | CMS |
| Lilly USA, LLC | $20.78 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135828837 | CMS |
| Novo Nordisk Inc | $19.12 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100306477 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.33 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144633645 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.